Determination of the Required Sample Size with Assurance for ThreeArm Non- Inferiority Trials

被引:0
作者
Azmee, Nor Afzalina [1 ]
Mohamed, Zulkifley [1 ]
Ahmad, Azhar [1 ]
机构
[1] Univ Pendidikan Sultan Idris, Fac Sci & Math, Dept Math, Tanjung Malim 35900, Perak, Malaysia
来源
JURNAL TEKNOLOGI | 2013年 / 63卷 / 02期
关键词
Assurance; power; non; inferiority trial; three; arm design; BCTS;
D O I
暂无
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
The concept of assurance in the two-arm non-inferiority trials has been explored, expressing the noninferiority margin as a clinically meaningful treatment difference. This short paper focuses on developing an assurance formula in the three-arm non-inferiority trial, based on the ratio of means. The discussion starts with the simple case of known variances and then extends to the case of unknown but equal variances. To avoid complicated integration, assurance for the latter case was studied using Bayesian Clinical Trial Simulation (BCTS). The findings indicate that assurance allows the experimenter to formally take into account the uncertainty surrounding the parameter estimates by using the prior distributions. Furthermore, BCTS can be easily implemented to find the required sample size without having to resort to complex integration.
引用
收藏
页数:5
相关论文
共 12 条
[1]   METAANALYSIS OF CLINICAL-TRIALS AS A SCIENTIFIC DISCIPLINE .1. CONTROL OF BIAS AND COMPARISON WITH LARGE COOPERATIVE TRIALS [J].
CHALMERS, TC ;
LEVIN, H ;
SACKS, HS ;
REITMAN, D ;
BERRIER, J ;
NAGALINGAM, R .
STATISTICS IN MEDICINE, 1987, 6 (03) :315-&
[2]   Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials [J].
Daimon, Takashi .
CONTEMPORARY CLINICAL TRIALS, 2008, 29 (04) :507-516
[3]   25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel [J].
Grieve, Andrew P. .
PHARMACEUTICAL STATISTICS, 2007, 6 (04) :261-281
[4]   Assurance in clinical trial design [J].
O'Hagan, A ;
Stevens, JW ;
Campbell, MJ .
PHARMACEUTICAL STATISTICS, 2005, 4 (03) :187-201
[5]   Bayesian assessment of sample size for clinical trials of cost-effectiveness [J].
O'Hagan, A ;
Stevens, JW .
MEDICAL DECISION MAKING, 2001, 21 (03) :219-230
[6]   Bayesian techniques for sample size determination in clinical trials: a short review [J].
Pezeshk, H .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2003, 12 (06) :489-504
[7]   Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo [J].
Pigeot, I ;
Schäfer, J ;
Röhmel, J ;
Hauschke, D .
STATISTICS IN MEDICINE, 2003, 22 (06) :883-899
[8]   CAN WE LEARN ANYTHING FROM SMALL TRIALS [J].
SACKETT, DL ;
COOK, DJ .
DOING MORE GOOD THAN HARM: THE EVALUATION OF HEALTH CARE INTERVENTIONS, 1993, 703 :25-32
[9]   Epidemiology 1 - Sample size calculations in randomised trials: mandatory and mystical [J].
Schulz, KF ;
Grimes, DA .
LANCET, 2005, 365 (9467) :1348-1353
[10]  
Simon R, 2000, STAT SCI, V15, P103